Aarti Pharmalabs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2025
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs held its 6th AGM on September 22, 2025, via video conferencing, chaired by Rashesh C. Gogri with Vice Chairperson & MD Hetal Gogri Gala and MD Narendra Salvi present, along with all committee heads and auditors. Both the Statutory and Secretarial Auditor reports were unqualified, indicating a clean audit for FY24-25. CFO Piyush Lakhani presented an overview of the company's FY24-25 financial performance. Shareholders considered 8 resolutions covering: adoption of audited FY24-25 financial statements, declaration of a final dividend on equity shares, re-appointment of a director retiring by rotation, re-appointment of an Independent Director, ratification of cost auditor remuneration, appointment of a secretarial auditor for 5 years, revision in MD remuneration, and extension of ESOP benefits to employees of subsidiary companies. The meeting concluded at 11:33 AM, and the results of remote e-voting and AGM e-voting will be declared within 2 working days.
The proceedings confirm a clean audit, continuity in leadership via director re-appointments, and the Board's recommendation of a final dividend for FY24-25. Investors should watch for the formal voting results within 2 working days, which will confirm the final dividend, the MD's revised remuneration, and the extension of stock option benefits to subsidiary employees.